Blood pressure control early in diabetes: A balance between angiotensin II and nitric oxide

Michael W. Brands, Sharyn M. Fitzgerald

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

1. Hyperglycaemia can lead to hypertension in longstanding diabetes through cumulative effects to cause progressive glomerular injury. However, it is not known how hyperglycaemia directly affects blood pressure control. Moreover, it has been difficult to isolate the actions of hyperglycaemia from other factors that can influence blood pressure. Recent studies at the earliest stages of type I diabetes have started to address these issues. 2. In humans and in animal models of type I diabetes, there is evidence that onset of hyperglycaemia can increase blood pressure. The increase is mild and has been linked to angiotensin (Ang) II, possibly due to slight overstimulation of the system in response to hyperglycaemia. 3. We have reported recently that onset of hyperglycaemia causes severe hypertension in rats that are treated chronically with NG-nitro-L-arginine methyl ester and the hypertension is accompanied by a progressive increase in AngII and absence of hyperfiltration. This suggests that nitric oxide (NO), at the early stages of diabetes, is important in mediating the increase in glomerular filtration rate and in preventing hypertension. 4. We propose a hypothesis based on these results that hyperglycaemia at the earliest stages of diabetes induces hyperfiltration and natriuresis and also activates a compensatory hypertensive stimulus (likely AngII) in an attempt to maintain normal blood pressure. A critical balance exists between these forces and NO plays a pivotal role by attenuating AngII-mediated renal vasoconstriction and facilitating the increase in glomerular filtration rate.

Original languageEnglish (US)
Pages (from-to)127-131
Number of pages5
JournalClinical and Experimental Pharmacology and Physiology
Volume29
Issue number1-2
DOIs
StatePublished - Feb 5 2002

Fingerprint

Angiotensin II
Hyperglycemia
Nitric Oxide
Blood Pressure
Hypertension
Glomerular Filtration Rate
Type 1 Diabetes Mellitus
Natriuresis
NG-Nitroarginine Methyl Ester
Vasoconstriction
Animal Models
Kidney
Wounds and Injuries

Keywords

  • Glomerular filtration rate
  • Hypertension
  • Renal vascular resistance
  • Renin

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Blood pressure control early in diabetes : A balance between angiotensin II and nitric oxide. / Brands, Michael W.; Fitzgerald, Sharyn M.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 29, No. 1-2, 05.02.2002, p. 127-131.

Research output: Contribution to journalArticle

@article{937186da1e2043c79e96588b12a5b155,
title = "Blood pressure control early in diabetes: A balance between angiotensin II and nitric oxide",
abstract = "1. Hyperglycaemia can lead to hypertension in longstanding diabetes through cumulative effects to cause progressive glomerular injury. However, it is not known how hyperglycaemia directly affects blood pressure control. Moreover, it has been difficult to isolate the actions of hyperglycaemia from other factors that can influence blood pressure. Recent studies at the earliest stages of type I diabetes have started to address these issues. 2. In humans and in animal models of type I diabetes, there is evidence that onset of hyperglycaemia can increase blood pressure. The increase is mild and has been linked to angiotensin (Ang) II, possibly due to slight overstimulation of the system in response to hyperglycaemia. 3. We have reported recently that onset of hyperglycaemia causes severe hypertension in rats that are treated chronically with NG-nitro-L-arginine methyl ester and the hypertension is accompanied by a progressive increase in AngII and absence of hyperfiltration. This suggests that nitric oxide (NO), at the early stages of diabetes, is important in mediating the increase in glomerular filtration rate and in preventing hypertension. 4. We propose a hypothesis based on these results that hyperglycaemia at the earliest stages of diabetes induces hyperfiltration and natriuresis and also activates a compensatory hypertensive stimulus (likely AngII) in an attempt to maintain normal blood pressure. A critical balance exists between these forces and NO plays a pivotal role by attenuating AngII-mediated renal vasoconstriction and facilitating the increase in glomerular filtration rate.",
keywords = "Glomerular filtration rate, Hypertension, Renal vascular resistance, Renin",
author = "Brands, {Michael W.} and Fitzgerald, {Sharyn M.}",
year = "2002",
month = "2",
day = "5",
doi = "10.1046/j.1440-1681.2002.03619.x",
language = "English (US)",
volume = "29",
pages = "127--131",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "1-2",

}

TY - JOUR

T1 - Blood pressure control early in diabetes

T2 - A balance between angiotensin II and nitric oxide

AU - Brands, Michael W.

AU - Fitzgerald, Sharyn M.

PY - 2002/2/5

Y1 - 2002/2/5

N2 - 1. Hyperglycaemia can lead to hypertension in longstanding diabetes through cumulative effects to cause progressive glomerular injury. However, it is not known how hyperglycaemia directly affects blood pressure control. Moreover, it has been difficult to isolate the actions of hyperglycaemia from other factors that can influence blood pressure. Recent studies at the earliest stages of type I diabetes have started to address these issues. 2. In humans and in animal models of type I diabetes, there is evidence that onset of hyperglycaemia can increase blood pressure. The increase is mild and has been linked to angiotensin (Ang) II, possibly due to slight overstimulation of the system in response to hyperglycaemia. 3. We have reported recently that onset of hyperglycaemia causes severe hypertension in rats that are treated chronically with NG-nitro-L-arginine methyl ester and the hypertension is accompanied by a progressive increase in AngII and absence of hyperfiltration. This suggests that nitric oxide (NO), at the early stages of diabetes, is important in mediating the increase in glomerular filtration rate and in preventing hypertension. 4. We propose a hypothesis based on these results that hyperglycaemia at the earliest stages of diabetes induces hyperfiltration and natriuresis and also activates a compensatory hypertensive stimulus (likely AngII) in an attempt to maintain normal blood pressure. A critical balance exists between these forces and NO plays a pivotal role by attenuating AngII-mediated renal vasoconstriction and facilitating the increase in glomerular filtration rate.

AB - 1. Hyperglycaemia can lead to hypertension in longstanding diabetes through cumulative effects to cause progressive glomerular injury. However, it is not known how hyperglycaemia directly affects blood pressure control. Moreover, it has been difficult to isolate the actions of hyperglycaemia from other factors that can influence blood pressure. Recent studies at the earliest stages of type I diabetes have started to address these issues. 2. In humans and in animal models of type I diabetes, there is evidence that onset of hyperglycaemia can increase blood pressure. The increase is mild and has been linked to angiotensin (Ang) II, possibly due to slight overstimulation of the system in response to hyperglycaemia. 3. We have reported recently that onset of hyperglycaemia causes severe hypertension in rats that are treated chronically with NG-nitro-L-arginine methyl ester and the hypertension is accompanied by a progressive increase in AngII and absence of hyperfiltration. This suggests that nitric oxide (NO), at the early stages of diabetes, is important in mediating the increase in glomerular filtration rate and in preventing hypertension. 4. We propose a hypothesis based on these results that hyperglycaemia at the earliest stages of diabetes induces hyperfiltration and natriuresis and also activates a compensatory hypertensive stimulus (likely AngII) in an attempt to maintain normal blood pressure. A critical balance exists between these forces and NO plays a pivotal role by attenuating AngII-mediated renal vasoconstriction and facilitating the increase in glomerular filtration rate.

KW - Glomerular filtration rate

KW - Hypertension

KW - Renal vascular resistance

KW - Renin

UR - http://www.scopus.com/inward/record.url?scp=0036156134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036156134&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1681.2002.03619.x

DO - 10.1046/j.1440-1681.2002.03619.x

M3 - Article

C2 - 11906471

AN - SCOPUS:0036156134

VL - 29

SP - 127

EP - 131

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 1-2

ER -